Noida, India

Rambabu Guguloth

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 8.8

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2017-2019

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Inventor Profile: Rambabu Guguloth

Introduction

Rambabu Guguloth is an innovative inventor based in Noida, India. With a remarkable portfolio of two patents, he has made significant contributions in the field of heterocyclic compounds, particularly aimed at treating metabolic and hyperproliferative disorders.

Latest Patents

His latest patents include critical advancements in drug compounds and their applications. The first is titled "Heterocyclic compounds and methods of use," which delineates the usage of these compounds in the treatment of metabolic disorders and hyperproliferative disorders. This innovation emphasizes the administration of these compounds in synergy with hormone receptor antagonists, showcasing a novel approach in therapeutic strategies.

Career Highlights

Rambabu currently works with Medivation Technologies, Inc., an organization that focuses on the research and development of cutting-edge medical therapies. His work reflects a commitment to improving treatment options and enhancing patient outcomes through innovative solutions.

Collaborations

Throughout his career, Rambabu has collaborated with talented professionals, including his coworkers Roopa Rai and Son Minh Pham. These partnerships within the organization have facilitated a dynamic exchange of ideas and fostered advancements in their respective fields.

Conclusion

Rambabu Guguloth stands out as a dedicated inventor whose contributions to the realm of heterocyclic compounds offer promising advancements for medical science. His innovative spirit and collaborative efforts continue to pave the way for new treatments that can significantly impact health and wellbeing.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…